Provided by Tiger Trade Technology Pte. Ltd.

Vivani Medical, Inc.

1.38
-0.0300-2.13%
Post-market: 1.380.00000.00%19:30 EDT
Volume:104.74K
Turnover:146.97K
Market Cap:124.48M
PE:-3.91
High:1.44
Open:1.44
Low:1.37
Close:1.41
52wk High:1.92
52wk Low:0.9228
Shares:90.20M
Float Shares:36.87M
Volume Ratio:0.35
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3534
EPS(LYR):-0.4265
ROE:-220.40%
ROA:-48.48%
PB:6.56
PE(LYR):-3.24

Loading ...

Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)

TIPRANKS
·
Aug 18

Vivani Medical Posts Investor Deck Outlining NanoPortal Ultra-Long-Acting GLP-1 Implant Strategy for Obesity Market

Reuters
·
Aug 18

ClearOne Q2 FY26 Net Loss from Continuing Operations Narrows to $919,000; General and Administrative Expense Falls 22% to $849,000

Reuters
·
Aug 15

Lake Street Remains a Buy on Vivani Medical (VANI)

TIPRANKS
·
Aug 14

Vivani Medical Q2 EPS USD -0.07

THOMSON REUTERS
·
Aug 14

Vivani Medical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Vivani Medical Q2 EPS $(0.07) Beats $(0.08) Estimate

Benzinga Earnings
·
Aug 14

Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 14

Vivani Medical Q2 FY26 Net Loss Narrows 9.86% to $6.4 Million

Reuters
·
Aug 14

ClearOne Shareholders Back Issuance of 12,500,000 Shares for Cortigent Merger by Written Consent

Reuters
·
Aug 11

Vivani Medical Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Vivani Medical Completes Dosing in SLIM-1 Phase 1 Trial of NPM-139 Semaglutide Implant for Weight Management

Reuters
·
Aug 06

Vivani Medical Announces Successful Dosing of All Participants in Slim-1, a Phase 1 Trial Evaluating Npm-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

THOMSON REUTERS
·
Aug 06

ClearOne Cancels Warrants for 437,500 Shares at $5 Exercise Price

Reuters
·
Aug 06

Clearone Files Draft Information Statement for Cortigent Merger Share Issuance

Reuters
·
Jul 18

Vivani Medical Director, 10% Owner Gregg Williams Reports Purchase of USD 999,999 Common Shares

Reuters
·
Jul 16

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

GlobeNewswire
·
Jul 15

Vivani Medical Signs Deal with Novo Nordisk to Evaluate Npm-139 Semaglutide Implant

Reuters
·
Jul 08

Vivani Medical Publishes Investor Presentation on Nanoportal Long-acting GLP-1 Implant Pipeline for Obesity

Reuters
·
Jul 08

Sector Update: Healthcare

MT Newswires Live
·
Jul 07